Cargando…
Combination of GC-MS based metabolomics analysis with mouse xenograft models reveals a panel of dysregulated circulating metabolites and potential therapeutic targets for colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is a common gastrointestinal tumor with subtle, often undetectable early symptoms, which means that upon diagnosis, patients often present in the middle or late stages of disease. Therefore, the need for an effective biomarker for the early diagnosis and developme...
Autores principales: | Ni, Juan, Chen, Yang, Li, Ningning, Sun, Diandian, Ju, Haixing, Chen, Zhongjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797830/ https://www.ncbi.nlm.nih.gov/pubmed/35116504 http://dx.doi.org/10.21037/tcr-20-3406 |
Ejemplares similares
-
Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer
por: Zhu, Guoxue, et al.
Publicado: (2021) -
Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS
por: Zhang, Ziyan, et al.
Publicado: (2022) -
Metabolomics Benefits from Orbitrap GC–MS—Comparison of Low- and High-Resolution GC–MS
por: Stettin, Daniel, et al.
Publicado: (2020) -
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
por: Gao, Yun, et al.
Publicado: (2022) -
Metabolomics based on GC-MS revealed hub metabolites of pecan seeds germinating at different temperatures
por: Xue, Tingting, et al.
Publicado: (2023)